Teva UK said that its Dorzolamide/Timolol 20mg/5mg per ml ophthalmic solution is a generic version of Merck Sharp & Dohme’s Cosopt.
Dorzolamide HCl /Timolol Maleate ophthalmic solution is the combination of a topical carbonic anhydrase inhibitor and a topical beta-adrenergic receptor blocking agent.
Dorzolamide hydrochloride is described chemically as: (4S-trans)-4-(ethylamino)-5,6-dihydro-6-methyl-4Hthieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide monohydrochloride. Dorzolamide Hydrochloride is optically active.
Teva UK commercial director Kim Innes said that they are pleased to add this product to product portfolio.